MedTrace Logo

Two Daily Disposable Contact Lenses in Symptomatic Patients

NCT03628599 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2019-07-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the performance of DAILIES TOTAL1® and ACUVUE OASYS® 1-DAY and with respect to visual acuity in a symptomatic study population of monthly or bi-weekly replacement lens wearers.

Conditions

  • Myopia

Interventions

DEVICE

Delefilcon A contact lenses

Water Gradient silicon hydrogel daily disposable contact lenses

DEVICE

Senofilcon A contact lenses

Silicon hydrogel daily disposable contact lenses with HydraLuxe™ Technology

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Alcon Research · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-13
Primary Completion
2018-09-25
Completion
2018-09-25
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03628599 on ClinicalTrials.gov